Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Harnessing the reverse cholesterol transport pathway to favor differentiation of monocyte-derived APCs and antitumor responses.

Cell death & disease·2023
Same author

The estrogen receptor α-selective agonist propyl pyrazole triol improves glucose tolerance in ob/ob mice: potential molecular mechanisms

The Journal of endocrinology·2020
Same author

ERα expression in T lymphocytes is dispensable for estrogenic effects in bone.

The Journal of endocrinology·2018
Same author

The role of membrane ERα signaling in bone and other major estrogen responsive tissues.

Scientific reports·2016
Same author

Liver X receptors regulate cerebrospinal fluid production.

Molecular psychiatry·2015
Same author

ERβ decreases breast cancer cell survival by regulating the IRE1/XBP-1 pathway.

Oncogene·2014
Same journal

News from the European Academy of Andrology (EAA).

International journal of andrology·2018
Same journal

The EAA International Quality Control Programme for Y-Chromosomal Microdeletions.

International journal of andrology·2018
Same journal

Cell surface molecules of human teratoma cell lines.

International journal of andrology·2017
Same journal

Foreword.

International journal of andrology·2017
Same journal

Discussion.

International journal of andrology·2017
Same journal

Discussion.

International journal of andrology·2017
See all related articles

Related Experiment Video

Updated: Jun 17, 2026

Methods to Test Endocrine Disruption in Drosophila melanogaster
09:43

Methods to Test Endocrine Disruption in Drosophila melanogaster

Published on: July 3, 2019

Endocrine disruptors targeting ERbeta function.

E Swedenborg1, I Pongratz, J-A Gustafsson

  • 1Department of Biosciences and Nutrition, Karolinska Institutet at Novum, Huddinge, Sweden. elin.swedenborg@ki.se

International Journal of Andrology
|January 7, 2010
PubMed
Summary
This summary is machine-generated.

Environmental endocrine disrupting chemicals (EDCs) pose risks by interfering with estrogen receptors (ERs). This review explores EDCs targeting ERbeta and aryl hydrocarbon receptor (AhR) interactions, examining health implications.

More Related Videos

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse
04:14

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse

Published on: October 6, 2023

Related Experiment Videos

Last Updated: Jun 17, 2026

Methods to Test Endocrine Disruption in Drosophila melanogaster
09:43

Methods to Test Endocrine Disruption in Drosophila melanogaster

Published on: July 3, 2019

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse
04:14

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse

Published on: October 6, 2023

Area of Science:

  • Environmental toxicology
  • Endocrinology
  • Molecular biology

Background:

  • Endocrine disrupting chemicals (EDCs) are prevalent environmental contaminants.
  • These chemicals pose risks to ecosystems, wildlife, and human health.
  • Oestrogen receptors (ERs), specifically ERalpha and ERbeta, are key targets for many EDCs, but mechanisms and long-term effects remain unclear.

Purpose of the Study:

  • To review EDCs that target ERbeta.
  • To describe the effects of aryl hydrocarbon receptor (AhR) activities on the oestrogen system.
  • To discuss the mechanisms and potential adverse health effects of EDC-ER interactions.

Main Methods:

  • Literature review of studies on EDCs, ERbeta, and AhR.
  • Analysis of molecular mechanisms underlying EDC action.
  • Synthesis of evidence regarding health consequences.

Main Results:

  • Several EDCs target ERbeta, influencing oestrogen pathways.
  • The aryl hydrocarbon receptor (AhR) plays a role in cellular defense and interacts with the oestrogen system.
  • Complex interplay exists between AhR and ER pathways.

Conclusions:

  • Understanding EDC-ERbeta interactions and AhR pathways is crucial.
  • Further research is needed to elucidate long-term health consequences.
  • Mitigation strategies for EDC exposure may be informed by these findings.